文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

法布雷病左心室肥厚的发生率与危险因素

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease.
PubMed 文献 · Heart · 2024-05-23

该观察性队列研究纳入214例基线无左心室肥厚(LVH)的法布雷病(FD)成人患者,中位随访9.4年,24.6%发生LVH,5年、10年、15年估计发生率分别为11.3%、29.1%、45.0%;年龄、男性及心电图异常为独立预测因素。

要点

  • 基线无LVH的法布雷病患者中位随访9.4年,24.6%出现LVH。
  • LVH估计发生率5年11.3%、10年29.1%、15年45.0%。
  • 年龄增长、男性、心电图异常独立预测LVH发生。

核心结论

  • 约四分之一基线无LVH的法布雷病患者在随访期间发生LVH。
  • 年龄、男性及心电图异常与LVH发生风险升高相关。

研究设计与样本

  • 观察性队列研究,连续纳入393例成人FD患者,其中214例基线无LVH(年龄35.8±13.8岁;61例男性,占29%)。
  • 在专科心肌病中心前瞻性随访,主要终点为首次检出LVH(男性LVMi≥115 g/m2,女性≥95 g/m2)。

主要发现

  • 中位随访9.4年(IQR 4.7-12.7),55例(24.6%)发生LVH。
  • LVH估计发生率:5年11.3%(95%CI 6.5%-16.1%),10年29.1%(95%CI 21.5%-36.7%),15年45.0%(95%CI 33.8%-62.4%)。
  • 多变量分析独立预测因素:年龄每增加1岁HR 1.04(95%CI 1.02-1.06),p<0.001;男性HR 2.90(95%CI 1.66-5.09),p<0.001;心电图异常HR 3.10(95%CI 1.72-5.57),p<0.001。
  • LVMi年变化率:男性+2.77(IQR 1.45-4.62)g/m2/年,女性+1.38(IQR 0.09-2.85)g/m2/年(p<0.001)。

关键数值与推荐

  • LVH定义:左心室质量指数(LVMi)男性≥115 g/m2,女性≥95 g/m2。

临床怎么用

  • 对基线无LVH的法布雷病患者,尤其高龄、男性或心电图异常者,应规律监测LVMi以早期检出LVH。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left ventricular hypertrophy (LVH) is the principal cardiac manifestation of Fabry disease (FD). This study aimed to determine the incidence and predictors of LVH development in a contemporary cohort of patients with FD and no LVH at baseline evaluation. METHODS: Consecutively referred adult (aged ≥16 years) patients with FD were enrolled into an observational cohort study. Patients were prospectively followed in a specialist cardiomyopathy centre and the primary endpoint was the first detection of LVH (left ventricular mass index (LVMi) ≥115 g/m2 in men and ≥95 g/m2 in women). RESULTS: From a cohort of 393 patients, 214 (aged 35.8±13.8 years; 61 (29%) males) had no LVH at first evaluation. During a median follow-up of 9.4 years (IQR 4.7-12.7), 55 patients (24.6%) developed LVH. The estimated incidence of LVH was 11.3% (95% CI 6.5% to 16.1%) at 5 years, 29.1% (95% CI 21.5% to 36.7%) at 10 years and 45.0% (95% CI 33.8% to 62.4%) at 15 years of follow-up. On multivariable analysis, independent predictors for LVH development were age (HR 1.04 (95% CI 1.02 to 1.06) per 1-year increase, p<0.001), male sex (HR 2.90 (95% CI 1.66 to 5.09), p<0.001) and an abnormal ECG (HR 3.10 (95% CI 1.72 to 5.57), p<0.001). The annual rate of change in LVMi was +2.77 (IQR 1.45-4.62) g/m2/year in males and +1.38 (IQR 0.09-2.85) g/m2/year in females (p<0.001). CONCLUSIONS: Approximately one-quarter of patients with FD developed LVH during follow-up. Age, male sex and ECG abnormalities were associated with a higher risk of developing LVH in patients with FD.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Monda E, Bakalakos A, Lachmann R, et al. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart. 2024. PMID: 38688703. doi:10.1136/heartjnl-2023-323783

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。